Cogent Biosciences
COGT
COGT
112 hedge funds and large institutions have $633M invested in Cogent Biosciences in 2022 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 43 increasing their positions, 19 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
29% more funds holding
Funds holding: 87 → 112 (+25)
7.24% more ownership
Funds ownership: 103.08% → 110.32% (+7.2%)
10% less call options, than puts
Call options by funds: $2.12M | Put options by funds: $2.35M
Holders
112
Holding in Top 10
9
Calls
$2.12M
Puts
$2.35M
Top Buyers
| 1 | +$38.6M | |
| 2 | +$26.6M | |
| 3 | +$13M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
+$11.1M |
| 5 |
FFM
Fairmount Funds Management
West Conshohocken,
Pennsylvania
|
+$10.8M |
Top Sellers
| 1 | -$9.33M | |
| 2 | -$7.22M | |
| 3 | -$6.39M | |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$5.03M |
| 5 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
-$4.53M |